Ptc Therapeutics (PTCT) Enterprise Value Growth (1y) (2013 - 2026)
Ptc Therapeutics (PTCT) Enterprise Value Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ptc Therapeutics | 6.34 Bn | 4.45 Bn | 244.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.65% |
| Dec 31, 2025 | -70.69% |
| Sep 30, 2025 | -66.56% |
| Jun 30, 2025 | -81.94% |
| Mar 31, 2025 | -129.11% |
| Dec 31, 2024 | -29.99% |
| Sep 30, 2024 | -243.73% |
| Jun 30, 2024 | -223.51% |
| Mar 31, 2024 | -209.05% |
| Dec 31, 2023 | -113.47% |
| Sep 30, 2023 | -2.21% |
| Jun 30, 2023 | 33.15% |
| Mar 31, 2023 | 51.29% |
| Dec 31, 2022 | 46.89% |
| Sep 30, 2022 | 66.77% |
| Jun 30, 2022 | 46.62% |
| Mar 31, 2022 | 40.53% |
| Dec 31, 2021 | 29.93% |
| Sep 30, 2021 | 23.93% |
| Jun 30, 2021 | -89.84% |